Nieuwe productintegratie breidt het aanbod voor Veeva en Salesforce gezamenlijke klanten uit
BARCELONA, Spanje-(BUSINESS WIRE)- Veeva Systems (NYSE:VEEV) heeft vandaag de MuleSoft Connector voor Veeva Vault aangekondigd. MuleSoft, een Salesforce bedrijf, werkt samen met Veeva om het voor life sciences bedrijven sneller en gemakkelijker te maken om Veeva Vault applicaties te verbinden met andere bedrijfssystemen. Deze nieuwste productintegratie bouwt voort op Veeva’s track record van innovatie voor gezamenlijke Salesforce-klanten.
“We zijn verheugd om samen te werken met Veeva om nieuwe innovatie te leveren aan de life sciences industrie”, zegt Brian Miller, senior vice president van business development, MuleSoft. “Het ecosysteem van MuleSoft wordt gedreven door de expertise van succesvolle partners zoals Veeva die klanten helpen de voordelen van het applicatienetwerk te realiseren.”
Veeva and MuleSoft Introduce MuleSoft Connector for Veeva Vault
New product integration expands offerings for Veeva and Salesforce joint customers
BARCELONA, Spain–(BUSINESS WIRE)– Veeva Systems (NYSE:VEEV) today announced the MuleSoft Connector for Veeva Vault. MuleSoft, a Salesforce company, is working together with Veeva to make it faster and easier for life sciences companies to connect Veeva Vault applications with other enterprise systems. This latest product integration builds upon Veeva’s track record of innovation for joint Salesforce customers.
“We’re excited to partner with Veeva to deliver new innovation to the life sciences industry,” said Brian Miller, senior vice president of business development, MuleSoft. “The MuleSoft ecosystem is driven by the expertise of successful partners like Veeva that help customers realize the benefits of the application network. We look forward to helping the life sciences industry better understand the opportunity of API-led connectivity to drive digital transformation within their organizations.”
“We’re proud of our longstanding partnership with Salesforce and our ongoing collaboration to help move the industry forward,” said Avril England, general manager of Veeva Vault. “We look forward to our future success with MuleSoft and supporting the continued needs of customers.”
Life sciences customers rely on Veeva Vault for regulated processes and commonly integrate Veeva Vault applications with multiple enterprise systems. The MuleSoft Connector for Veeva Vault simplifies this integration by reducing the need to develop and maintain custom integration code. Customers can now easily configure flexible and secure integrations between Veeva Vault and third-party business applications.
Available now, the MuleSoft Connector for Veeva Vault is developed and supported by MuleSoft and technically certified by both MuleSoft and Veeva to drive joint customer success. Veeva has been a Salesforce partner for more than a decade, and today’s news builds on their history of collaboration.
To hear how Veeva and MuleSoft will make it faster and easier to connect Veeva Vault applications with enterprise systems, register for the upcoming webinar on Aug. 27. Also, learn more by attending the Veeva Commercial & Medical Summit Europe, 3-5 December, in Barcelona, Spain. The event is open to Veeva customers and invited guests. Register and view the agenda at veeva.com/eu/summit.
For more on Veeva Vault, visit: veeva.com/eu/Vault
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veeva_eu on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 750 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended April 30, 2019. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.